ImmunoCellular Therapeutics (IMUC) Reports Q3 Loss of $0.40
Tweet
Share
E-mailGet Alerts IMUC Hot Sheet
Join SI Premium – FREE
ImmunoCellular Therapeutics (NYSE: IMUC) reported Q3 EPS of ($0.40), versus ($1.58) reported last year.
For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carnival Corp. (CCL) Tops Q3 EPS by 8c
- Wells Fargo: '2027 S7P 500 Index target of 8,600-8,800'
- SU Group reports narrowed loss as revenue falls 20% in first half
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
